Forebrain EAAT3 Overexpression Increases Susceptibility to Amphetamine-Induced Repetitive Behaviors
Copyright © 2024 Kopelman et al..
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder characterized by intrusive obsessive thoughts and compulsive behaviors. Multiple studies have shown the association of polymorphisms in the SLC1A1 gene with OCD. The most common of these OCD-associated polymorphisms increases the expression of the encoded protein, excitatory amino acid transporter 3 (EAAT3), a neuronal glutamate transporter. Previous work has shown that increased EAAT3 expression results in OCD-relevant behavioral phenotypes in rodent models. In this study, we created a novel mouse model with targeted, reversible overexpression of Slc1a1 in forebrain neurons. The mice do not have a baseline difference in repetitive behavior but show increased hyperlocomotion following a low dose of amphetamine (3 mg/kg) and increased stereotypy following a high dose of amphetamine (8 mg/kg). We next characterized the effect of amphetamine on striatal cFos response and found that amphetamine increased cFos throughout the striatum in both control and Slc1a1-overexpressing (OE) mice, but Slc1a1-OE mice had increased cFos expression in the ventral striatum relative to controls. We used an unbiased machine classifier to robustly characterize the behavioral response to different doses of amphetamine and found a unique response to amphetamine in Slc1a1-OE mice, relative to controls. Lastly, we found that the differences in striatal cFos expression in Slc1a1-OE mice were driven by cFos expression specifically in D1 neurons, as Slc1a1-OE mice had increased cFos in D1 ventral medial striatal neurons, implicating this region in the exaggerated behavioral response to amphetamine in Slc1a1-OE mice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
eNeuro - 11(2024), 4 vom: 19. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kopelman, Jared M [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 15.04.2024 Date Revised 25.04.2024 published: Electronic-Print Citation Status MEDLINE |
---|
doi: |
10.1523/ENEURO.0090-24.2024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370037642 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370037642 | ||
003 | DE-627 | ||
005 | 20240425233242.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240323s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1523/ENEURO.0090-24.2024 |2 doi | |
028 | 5 | 2 | |a pubmed24n1386.xml |
035 | |a (DE-627)NLM370037642 | ||
035 | |a (NLM)38514191 | ||
035 | |a (PII)ENEURO.0090-24.2024 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kopelman, Jared M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Forebrain EAAT3 Overexpression Increases Susceptibility to Amphetamine-Induced Repetitive Behaviors |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2024 | ||
500 | |a Date Revised 25.04.2024 | ||
500 | |a published: Electronic-Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Kopelman et al. | ||
520 | |a Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder characterized by intrusive obsessive thoughts and compulsive behaviors. Multiple studies have shown the association of polymorphisms in the SLC1A1 gene with OCD. The most common of these OCD-associated polymorphisms increases the expression of the encoded protein, excitatory amino acid transporter 3 (EAAT3), a neuronal glutamate transporter. Previous work has shown that increased EAAT3 expression results in OCD-relevant behavioral phenotypes in rodent models. In this study, we created a novel mouse model with targeted, reversible overexpression of Slc1a1 in forebrain neurons. The mice do not have a baseline difference in repetitive behavior but show increased hyperlocomotion following a low dose of amphetamine (3 mg/kg) and increased stereotypy following a high dose of amphetamine (8 mg/kg). We next characterized the effect of amphetamine on striatal cFos response and found that amphetamine increased cFos throughout the striatum in both control and Slc1a1-overexpressing (OE) mice, but Slc1a1-OE mice had increased cFos expression in the ventral striatum relative to controls. We used an unbiased machine classifier to robustly characterize the behavioral response to different doses of amphetamine and found a unique response to amphetamine in Slc1a1-OE mice, relative to controls. Lastly, we found that the differences in striatal cFos expression in Slc1a1-OE mice were driven by cFos expression specifically in D1 neurons, as Slc1a1-OE mice had increased cFos in D1 ventral medial striatal neurons, implicating this region in the exaggerated behavioral response to amphetamine in Slc1a1-OE mice | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a D1-MSN | |
650 | 4 | |a DeepLabCut | |
650 | 4 | |a RNAScope | |
650 | 4 | |a amphetamine | |
650 | 4 | |a basal ganglia | |
650 | 4 | |a immediate early gene | |
650 | 4 | |a neurotransmitter transporters | |
650 | 4 | |a preclinical model | |
650 | 4 | |a repetitive behavior | |
650 | 4 | |a striatum | |
650 | 7 | |a Amphetamine |2 NLM | |
650 | 7 | |a CK833KGX7E |2 NLM | |
650 | 7 | |a Excitatory Amino Acid Transporter 3 |2 NLM | |
650 | 7 | |a Slc1a1 protein, mouse |2 NLM | |
700 | 1 | |a Chohan, Muhammad O |e verfasserin |4 aut | |
700 | 1 | |a Hsu, Alex I |e verfasserin |4 aut | |
700 | 1 | |a Yttri, Eric A |e verfasserin |4 aut | |
700 | 1 | |a Veenstra-VanderWeele, Jeremy |e verfasserin |4 aut | |
700 | 1 | |a Ahmari, Susanne E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t eNeuro |d 2014 |g 11(2024), 4 vom: 19. Apr. |w (DE-627)NLM245441794 |x 2373-2822 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2024 |g number:4 |g day:19 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1523/ENEURO.0090-24.2024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2024 |e 4 |b 19 |c 04 |